The General Company for Pharmaceutical and Medical Supplies in Samarra, one of the companies under the Iraqi Ministry of Industry and Minerals, has succeeded in producing a treatment that prevents "venous blood clots and blood coagulation." The spokesperson for the Ministry of Industry, Duha Al-Jubouri, stated that "the Samarra Pharmaceutical Company has succeeded in producing a new product named 'Riba Rock Sam', which is a tablet that will soon be available in the local market." She explained that "these tablets are used for the treatment of blood coagulation and the prevention of venous blood clots." Al-Jubouri confirmed that "this treatment has proven its high effectiveness compared to foreign imported counterparts through the results of research and exploratory batches that were manufactured according to international British pharmacopoeia standards." The spokesperson for the Ministry of Industry and Minerals emphasized that "the Samarra Pharmaceutical Company continues to produce new products that serve the Ministry of Health and the market."